The Hypertension Excellence Centre programme of the European Society of Hypertension – current status, activities and reshaping for the future
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
USING A CUMULATIVE LOW-DENSITY LIPOPROTEIN CHOLESTEROL MODELLING APPROACH TO ESTIMATE THE REDUCTION OF RISK OF ATHEROSCLEROTIC CARDIOVASCULAR EVENTS FROM A PRIMARY PREVENTION PROGRAM
Uut südamehaiguste ennetamises diabeetikutel Euroopa Kardioloogide Seltsi 2023. aasta ravijuhendis
Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)
Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment
Effectiveness and feasibility of cardiovascular disease personalised prevention on high polygenic risk score subjects: a randomised controlled pilot study
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Long-term stability of resting state EEG-based linear and nonlinear measures
Global perspective of familial hypercholesterolaemia: a cross sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)